FY26 Results Release
Filed with ASX · · 6 pages · English
up 14.1% to $43.6 million • Net debt up 67.2% to $10.7 million $32.8 million Healius Limited (Healius) today released results for the financial year ended 30 June 2026. FY 2026 was a year of significant operational improvement for Healius, with stronger underlying earnings, improved second-half Pathology margins and disciplined cost management offsetting continued sector volume and labour cost pre
Earlier from Healius
- FY26 Preliminary Final Report
- Healius transitions pathology arrangements with Ramsay
- FY26 trading update and strategic review of assets
- Healius announces 1H 2026 results
- Half Yearly Report and Accounts
Later from Healius
- FY26 Results Presentation
- S&P DJI Announces September 2026 Quarterly Rebalance
- Agreement to sell Agilex Biolabs to Novotech
Follow Healius into a list and get an email when it puts out news.
Follow Healius